16 results
8-K
EX-10.2
MYMD
MyMD Pharmaceuticals Inc
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
an original thereof.
(c) Headings; Gender. The headings of this Agreement are for convenience of reference and shall not form part of, or affect
8-K
EX-10.1
MYMD
MyMD Pharmaceuticals Inc
21 May 24
MyMD Pharmaceuticals Secures Strategic Investments
9:10am
an original thereof.
(c) Headings; Gender. The headings of this Agreement are for convenience of reference and shall not form part of, or affect
8-K
EX-10.4
MYMD
MyMD Pharmaceuticals Inc
21 Apr 21
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
9:56pm
not constitute substantive matters to be considered in construing the terms and provisions of this Agreement.
26. Gender and Number. Words of any gender … used in this Agreement shall be held and construed to include any other gender, and words in the singular number shall be held to include the plural
8-K
EX-10.6
wc7ka4hkv8w3sz
21 Apr 21
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
9:56pm
8-K
EX-10.5
vi9r6hrs6
21 Apr 21
Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger
9:56pm
S-4/A
EX-10.48
ge0t1ix7vyhhcpaa4vj5
19 Mar 21
Registration of securities issued in business combination transactions (amended)
2:01pm
8-K
EX-2.1
0hu6d
12 Nov 20
Akers Biosciences and MyMD Pharmaceuticals Sign Definitive Merger Agreement
5:26pm
8-K
EX-10.1
4twn0rn
10 Aug 20
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
5jrst5q 7jf7ab
7 Dec 18
Entry into a Material Definitive Agreement
5:15pm
- Prev
- 1
- Next